← Leaderboards
James M Foran
University Of Alabama At Birmingham
$50,669
Attributed
$50,669
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $23.3K · FY2005–07$25K$18.8K$12.5K$6.3K$0
'05
'06
'07
Funding mix
By agency
NIH$50,669 · 2
By mechanism
M01$50,669 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Elizabeth Ann Eklund$14,527,585
- Ravi Bhatia$16,631,024
- Ralph R Weichselbaum$16,065,057
- Eric Hunter$78,178,241
- Paul A. Goepfert$51,350,070
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisCellsClinical Trials, Phase IiClofarabineComputer Retrieval Of Information On Scientific Projects DatabaseCytotoxicDisease RemissionDoseDrug KineticsElderlyFundingGenesGrantInstitutionIn VitroIn VivoLeukemia, Myelocytic, AcuteMonitorPersonal SatisfactionPharmaceutical PreparationsQuality Of LifeQuestionnairesRangeRate
Grant awards (3)
A PHASE I/II STUDY OF CLOFARABINE FOR OLDER ADULTS WITH ACUTE MYELOID LEUKEMIA$23,250
M01 · FY2007 · RR · contact PI
A PHASE I/II STUDY OF CLOFARABINE FOR OLDER ADULTS WITH ACUTE MYELOID LEUKEMIA$4,935
M01 · FY2006 · RR · contact PI
A PHASE I/II STUDY OF CLOFARABINE FOR OLDER ADULTS WITH ACUTE MYELOID LEUKEMIA$22,484
M01 · FY2005 · RR